A new meningococcal vaccine was approved by the TGA last year. This month the Australian Technical Advisory Group on Immunisation has put out a recommendation about it. The present meningococcal vaccine already on the immunisation schedule is effective against serotype C, but this one is effective against the much more common serotype B.
Invasive meningococcal disease (IMD) is a really nasty disease and is the leading cause of meningitis and septicaemia globally. It tends to affect the under 5 year age group (with another peak in adolescence) and particularly attacks infants. The incidence in the under 1 year olds is […]